Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Opko Teams Up With Bristol-Myers For Alzheimers Effort
Forbes
Monday, January 10, 2011 - 8:12pm
tags:
OPKO Health, Alzheimer's disease, Bristol-Myers Squibb
Amgen Exec: “Clearly Superior” Prostate Cancer Drug Will Be Huge
Forbes
Monday, January 10, 2011 - 8:04pm
tags:
prostate cancer, Amgen, Prolia, Xgeva
Will Drug Repurposing Mean Healthy Profits?
Seeking Alpha
Monday, January 10, 2011 - 7:28pm
tags:
drug repurposing, Celgene, Merck, Pfizer
Epizyme, Glaxo sign deal worth up to $650M
Bizjournals.com
Monday, January 10, 2011 - 7:27pm
tags:
Epizyme, GSK, personalized medicine
Medicare contractor won't stop paying for Avastin
Fierce Pharma
Monday, January 10, 2011 - 12:40pm
tags:
Avastin, Medicare, Roche, Genentech, breast cancer
Sanofi Is Discussing Lemtrada Payments With Genzyme
Bloomberg
Monday, January 10, 2011 - 12:38pm
tags:
Sanofi, Lemtrada, Genzyme, MS, multiple sclerosis
InterMune to start new IPF drug trial
Bizjournals
Monday, January 10, 2011 - 12:37pm
tags:
IPF, InterMune, Esbriet
Exelixis cancer drug wins 'orphan' tag
Bizjournals.com
Monday, January 10, 2011 - 12:35pm
tags:
Exelixis, orphan drugs, XL-184, thyroid cancer
New Langer startup to develop oral insulin
Bizjournals.com
Monday, January 10, 2011 - 12:27pm
tags:
insulin, diabetes, Entrega
Vertex Expects an Eventful 2011
Yahoo/Zacks.com
Monday, January 10, 2011 - 12:26pm
tags:
Vertex Pharmaceuticals, JNJ
Bristol-Myers, Pharmasset plan hepatitis C study
Yahoo/AP
Monday, January 10, 2011 - 12:23pm
tags:
hepatitis C, Pharmasset, Bristol-Myers Squibb
Abbott Gets European Approval for Drug-Eluting Vascular Scaffold
Bloomberg
Monday, January 10, 2011 - 12:21pm
tags:
Abbott Laboratories, drug-eluting scaffold, Europe
Is $80 the Magic Number for Sanofi and Genzyme?
WSJ Online
Monday, January 10, 2011 - 12:20pm
tags:
Sanofi, Genzyme, M&A
Smith & Nephew Up on Reports of J&J Bid
TheStreet.com
Monday, January 10, 2011 - 12:18pm
tags:
Smith & Nephew, JNJ, M&A
Novartis plans trial of equivalent to Roche drug
Marketwatch
Monday, January 10, 2011 - 12:16pm
tags:
Roche, Novartis, biosimilars, Rituxan, Sandoz, rheumatoid arthritis, rituximab
Genentech Sued Over Withdrawn Psoriasis Drug Raptiva
Bloomberg
Monday, January 10, 2011 - 12:15pm
tags:
Genentech, psoriasis, Raptiva, lawsuits
Lilly pancreas drug raises questions-US FDA staff
Reuters
Monday, January 10, 2011 - 12:10pm
tags:
FDA, Eli Lilly, liprotamase, exocrine pancreatic insufficiency
Prozac Helps Stroke Patients Recover Motor Skills, Study Says
Bloomberg
Monday, January 10, 2011 - 12:08pm
tags:
Prozac, stroke, Eli Lilly
Sanofi-Genzyme Deal Talks Progress
NY Times, NY
Monday, January 10, 2011 - 12:02pm
tags:
Genzyme, Sanofi, M&A
Inhibitex Reports Positive Interim Safety and Antiviral Data from Ongoing Phase 1b Study of HCV Nucleotide Inhibitor INX-189
BusinessWire
Sunday, January 9, 2011 - 6:11pm
tags:
Inhibitex, INX-189, anti-viral, HIV, hepatitis C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.